Search

Novo Nordisk A-S

Закрыт

СекторЗдравоохранение

39.08 -0.64

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

38.4

Макс.

39.36

Ключевые показатели

By Trading Economics

Доход

-28B

21B

Продажи

-18B

78B

P/E

Средняя по отрасли

9.394

49.241

Прибыль на акцию

0.96

Дивидендная доходность

4.68

Рентабельность продаж

26.742

Сотрудники

66,700

EBITDA

-31B

39B

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+8.09% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

4.68%

2.15%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-39B

170B

Предыдущая цена открытия

39.72

Предыдущая цена закрытия

39.08

Novo Nordisk A-S График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

21 окт. 2026 г., 23:52 UTC

News

The Nikkei 225 Index is trading modestly lower in after-market hours, following a significant rise earlier in the day amid sector-specific movements.

21 окт. 2026 г., 23:51 UTC

News

Supernus Pharmaceuticals receives seven years of orphan-drug exclusivity from the FDA for ONAPGO, a treatment for motor fluctuations in advanced Parkinson's disease.

21 окт. 2026 г., 23:51 UTC

News

Regal Rexnord Corporation declared a quarterly dividend of $0.35 per share, payable on January 14, 2027, to shareholders on record as of December 31, 2026.

21 окт. 2026 г., 23:51 UTC

News

A class action lawsuit has been filed against AppLovin Corporation, alleging misleading statements about its generative AI video tool's development delays.

21 окт. 2026 г., 23:46 UTC

News

FMC Corporation is under investigation for securities fraud regarding undisclosed information related to its revised third-quarter guidance and significant EBITDA losses.

21 окт. 2026 г., 23:46 UTC

News

Wolfe Research initiates coverage on Ross Stores Inc. with an Outperform rating and a price target of $279.

21 окт. 2026 г., 23:41 UTC

News
Correlated Moves

BancFirst Corporation reported Q3 net income of $67.3 million, or $1.97 per diluted share, exceeding analyst expectations and up from $62.7 million year-over-year.

21 окт. 2026 г., 23:41 UTC

News

Norfolk Southern Corporation declared a quarterly dividend of $1.35 per share, payable on November 20, 2026, continuing its 177-quarter dividend payment streak.

21 окт. 2026 г., 23:31 UTC

News

Mid Penn Bancorp reported Q3 adjusted EPS of $0.88, missing the $0.89 estimate, and sales of $74.678 million, below expectations of $77.799 million.

21 окт. 2026 г., 23:31 UTC

Social Media
News

Southwest Airlines reported Q3 net income of $270 million, but lowered its Q4 adjusted EPS guidance to $0.55-$0.80, below market expectations of $0.81.

21 окт. 2026 г., 23:31 UTC

News
Macro News

UK Public Sector Net Borrowing for September reached £24.5 billion, exceeding forecasts, while consumer price inflation rose to 3.5%, fueling interest rate hike speculation.

21 окт. 2026 г., 23:31 UTC

Social Media
Correlated Moves
News

NVIDIA launches the Vera Rubin DSX POD to expedite AI infrastructure deployment, while Needham reiterates a Buy rating with a $300 price target.

21 окт. 2026 г., 23:31 UTC

News

United Airlines files an automatic mixed securities shelf for potential capital-raising efforts, amid strong third-quarter revenue growth of 17% year over year.

21 окт. 2026 г., 23:26 UTC

Social Media
News

Palantir Technologies announced multiple AI deployments with clients, including L3Harris and Nvidia, despite shares trading modestly lower in after-market hours.

21 окт. 2026 г., 23:26 UTC

Correlated Moves
News

Marvell Technology Inc. shares fell in after-market trading, reflecting a broader decline in the Nasdaq 100 Index amid Meta Platforms' user engagement report and fine.

21 окт. 2026 г., 23:21 UTC

News

Fulton Financial Corporation reports Q3 net income of $114.1 million, exceeding expectations with total revenue of $367.3 million, shares advance in after-market trading.

21 окт. 2026 г., 23:16 UTC

News

Coca-Cola Consolidated, Inc. will release its Q3 and first nine months 2026 operating results on November 4, 2026, after the market closes.

21 окт. 2026 г., 23:11 UTC

News

A securities class action lawsuit has been filed against Duolingo, alleging false statements about user growth and product quality from May 2025 to February 2026.

21 окт. 2026 г., 23:11 UTC

News

Robinhood Markets Inc. shares are moving lower after-market hours, reflecting a significant decline in the broader market following higher daily closes since Wednesday.

21 окт. 2026 г., 23:11 UTC

News

Bybit plans to enter the U.S. market via a brokerage partnership, increasing competition for Coinbase amid a broader market decline.

21 окт. 2026 г., 23:06 UTC

Correlated Moves
News

L3Harris Technologies explores proprietary AI models for mission systems, achieving a reported 95% cost reduction in early tests, according to Palantir.

21 окт. 2026 г., 23:06 UTC

News

The USD/HKD exchange rate is roughly flat, having dipped to a low point before midday while remaining near the upper end of its one-month trading range.

21 окт. 2026 г., 23:06 UTC

News

USD/SEK is trading lower, reflecting a decline from Tuesday's close amid reports of a decrease in the U.S. 30-year mortgage rate to 7.41%.

21 окт. 2026 г., 23:06 UTC

Social Media
News

Crown Castle Inc reported third-quarter earnings of $283 million, missing analyst expectations, with site rental revenues declining to $966 million.

21 окт. 2026 г., 23:06 UTC

News

Wolfe Research initiates coverage on Abercrombie & Fitch with an Outperform rating and a price target of $181.00.

21 окт. 2026 г., 23:06 UTC

News

Wolfe Research initiates coverage on Deckers Outdoor Corp with a Peerperform rating, as shares closed modestly lower in after-market trading.

21 окт. 2026 г., 23:06 UTC

News

Wolfe Research initiated coverage of DICK'S Sporting Goods with an Outperform rating and a price target of $181.00 amid a class action lawsuit.

21 окт. 2026 г., 23:06 UTC

News

SentinelOne expands partnership with N-able to enhance cybersecurity offerings, including AI and cloud solutions for U.S. government entities.

21 окт. 2026 г., 23:06 UTC

News

Bank of America faces scrutiny from a securities fraud lawsuit over anti-money laundering compliance, following a $1.2 billion fine from the Treasury.

21 окт. 2026 г., 23:06 UTC

News

Boeing Co shares are trading lower in after-market hours, reflecting a decline despite the announcement of its AI platform Dataliner developed with Microsoft.

Сравнение c конкурентами

Изменение цены

Novo Nordisk A-S Прогноз

Целевая цена

By TipRanks

8.09% рост

Прогноз на 12 месяцев

Средняя 42.533 USD  8.09%

Максимум 47 USD

Минимум 40 USD

Основано на мнении 7 аналитиков Wall Street, спрогнозировавших целевые цены для Novo Nordisk A-S на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

7 ratings

0

Покупка

6

Удержание

1

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Novo Nordisk A-S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
help-icon Live chat